Home ETF List About

Portfolio Holdings Detail for ISIN IE00B8FHGS14
Stock Name / FundiShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerMINV(GBX) LSE
ETF TickerIQQ0(EUR) F
ETF TickerMINV.LS(GBX) CXE
ETF TickerMVOL.LS(USD) CXE
ETF TickerMVOL.MI(EUR) CXE
ETF TickerMVOLz(CHF) CXE
ETF TickerMVOL(EUR) ETF Plus
ETF TickerMINV.L(GBP) LSE

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc) INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2025-11-11 (Tuesday)111,401USD 12,049,132INCY holding increased by 242854USD 12,049,1320USD 242,854 USD 108.16 USD 105.98
2025-11-10 (Monday)111,401USD 11,806,278USD 11,806,2780USD 0 USD 105.98 USD 105.98
2025-11-07 (Friday)111,401USD 11,806,278INCY holding increased by 86893USD 11,806,2780USD 86,893 USD 105.98 USD 105.2
2025-11-06 (Thursday)111,401USD 11,719,385INCY holding decreased by -55701USD 11,719,3850USD -55,701 USD 105.2 USD 105.7
2025-11-05 (Wednesday)111,401USD 11,775,086INCY holding increased by 309695USD 11,775,0860USD 309,695 USD 105.7 USD 102.92
2025-11-04 (Tuesday)111,401INCY holding decreased by -1064USD 11,465,391INCY holding increased by 42321USD 11,465,391-1,064USD 42,321 USD 102.92 USD 101.57
2025-11-03 (Monday)112,465USD 11,423,070INCY holding increased by 909842USD 11,423,0700USD 909,842 USD 101.57 USD 93.48
2025-10-31 (Friday)112,465INCY holding increased by 504USD 10,513,228INCY holding increased by 146759USD 10,513,228504USD 146,759 USD 93.48 USD 92.59
2025-10-30 (Thursday)111,961USD 10,366,469INCY holding increased by 269826USD 10,366,4690USD 269,826 USD 92.59 USD 90.18
2025-10-29 (Wednesday)111,961USD 10,096,643INCY holding decreased by -164583USD 10,096,6430USD -164,583 USD 90.18 USD 91.65
2025-10-28 (Tuesday)111,961INCY holding decreased by -1008USD 10,261,226INCY holding decreased by -253929USD 10,261,226-1,008USD -253,929 USD 91.65 USD 93.08
2025-10-27 (Monday)112,969USD 10,515,155INCY holding increased by 203345USD 10,515,1550USD 203,345 USD 93.08 USD 91.28
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00B8FHGS14

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-04SELL-1,064103.860100.020 100.404USD -106,830 71.26 Loss of -31,006 on sale
2025-10-31BUY50495.10092.058 92.362USD 46,550 71.00
2025-10-28SELL-1,00891.65093.980 93.747USD -94,497 70.68 Loss of -23,255 on sale
2025-10-21SELL-1,00887.30087.480 87.462USD -88,162 70.17 Loss of -17,432 on sale
2025-10-14SELL-50485.96086.160 86.140USD -43,415 69.71 Loss of -8,282 on sale
2025-10-02SELL-2,04786.28088.660 88.422USD -181,000 69.52 Loss of -38,690 on sale
2025-09-25SELL-50481.66084.450 84.171USD -42,422 69.11 Loss of -7,590 on sale
2025-09-24SELL-2,17684.16084.820 84.754USD -184,425 69.03 Loss of -34,226 on sale
2025-09-16BUY46683.90084.580 84.512USD 39,383 68.75
2025-07-23SELL-1,76370.69070.830 70.816USD -124,849 67.82 Loss of -5,286 on sale
2025-07-22SELL-2,30068.90069.120 69.098USD -158,925 67.81 Loss of -2,961 on sale
2025-07-21SELL-1,14867.38068.630 68.505USD -78,644 67.81 Loss of -794 on sale
2025-07-15SELL-2,29668.25070.150 69.960USD -160,628 67.79 Loss of -4,974 on sale
2025-07-11SELL-1,14868.59069.970 69.832USD -80,167 67.77 Loss of -2,363 on sale
2025-07-02BUY57368.17069.100 69.007USD 39,541 67.74
2025-06-30SELL-1,72868.10068.820 68.748USD -118,797 67.74 Loss of -1,745 on sale
2025-06-27SELL-1,86968.37071.120 70.845USD -132,409 67.73 Loss of -5,815 on sale
2025-06-26BUY57570.81071.500 71.431USD 41,073 67.71
2025-06-25SELL-57667.55069.140 68.981USD -39,733 67.71 Loss of -730 on sale
2025-06-16SELL-5,86071.22071.290 71.283USD -417,718 67.66 Loss of -21,226 on sale
2025-06-13SELL-57767.75068.960 68.839USD -39,720 67.66 Loss of -680 on sale
2025-06-12SELL-1,15269.22069.540 69.508USD -80,073 67.65 Loss of -2,142 on sale
2025-06-11SELL-2,88068.85070.360 70.209USD -202,202 67.64 Loss of -7,401 on sale
2025-06-09SELL-57669.89069.960 69.953USD -40,293 67.60 Loss of -1,354 on sale
2025-05-30SELL-57365.06065.770 65.699USD -37,646 67.64 Profit of 1,113 on sale
2025-05-28SELL-57164.93065.610 65.542USD -37,424 67.68 Profit of 1,219 on sale
2025-05-21SELL-57164.78065.460 65.392USD -37,339 67.81 Profit of 1,380 on sale
2025-05-14SELL-7,56661.16062.500 62.366USD -471,861 68.01 Profit of 42,724 on sale
2025-05-09BUY2,95158.98060.480 60.330USD 178,034 68.23
2025-05-07SELL-2,27659.55060.070 60.018USD -136,601 68.39 Profit of 19,058 on sale
2025-05-01BUY56962.03062.640 62.579USD 35,607 68.66
2025-04-29SELL-6,23760.43060.720 60.691USD -378,530 68.80 Profit of 50,584 on sale
2025-04-28SELL-57159.52059.600 59.592USD -34,027 68.90 Profit of 5,312 on sale
2025-04-25BUY57159.16059.210 59.205USD 33,806 68.99
2025-04-23BUY7,83458.00059.010 58.909USD 461,493 69.21
2025-04-22BUY5,01357.38058.040 57.974USD 290,624 69.34
2025-04-15SELL-1,66858.46059.950 59.801USD -99,748 69.83 Profit of 16,728 on sale
2025-04-14BUY2,91859.22059.300 59.292USD 173,014 69.95
2025-04-11BUY2,81356.87057.070 57.050USD 160,482 70.09
2025-04-09SELL-1,65958.86059.370 59.319USD -98,410 70.40 Profit of 18,375 on sale
2025-04-08SELL-2,21656.97061.470 61.020USD -135,220 70.55 Profit of 21,121 on sale
2025-04-07SELL-55460.29061.060 60.983USD -33,785 70.67 Profit of 5,368 on sale
2025-04-04BUY55660.58063.570 63.271USD 35,179 70.79
2025-04-01BUY2,22060.91062.000 61.891USD 137,398 71.02
2025-03-27SELL-1,11460.68061.640 61.544USD -68,560 71.41 Profit of 10,992 on sale
2025-03-21SELL-55761.92062.330 62.289USD -34,695 71.91 Profit of 5,360 on sale
2025-03-14BUY1,67467.86068.120 68.094USD 113,989 72.61
2025-03-13BUY55867.71068.970 68.844USD 38,415 72.68
2025-03-12BUY1,11667.73068.230 68.180USD 76,089 72.75
2025-03-11BUY1,11668.07071.650 71.292USD 79,562 72.82
2025-03-10SELL-55771.13071.890 71.814USD -40,000 72.85 Profit of 576 on sale
2025-03-07BUY9,41870.79072.810 72.608USD 683,822 72.88
2025-03-05BUY2,78069.81069.970 69.954USD 194,472 72.93
2025-03-04BUY1,11269.68070.000 69.968USD 77,804 72.98
2025-03-03BUY2,22470.26073.450 73.131USD 162,643 73.02
2025-02-27BUY55673.18074.600 74.458USD 41,399 73.01
2025-02-26BUY4,43274.30075.310 75.209USD 333,326 72.99
2025-02-25BUY1,10874.40076.240 76.056USD 84,270 72.97
2025-02-20BUY1,66271.38071.520 71.506USD 118,843 72.99
2025-02-05BUY55375.26075.740 75.692USD 41,858 73.51
2025-02-04BUY55374.12074.920 74.840USD 41,387 73.49
2025-01-31SELL-55174.16075.180 75.078USD -41,368 73.47 Loss of -886 on sale
2025-01-30BUY55173.77074.560 74.481USD 41,039 73.46
2025-01-29SELL-55173.72074.110 74.071USD -40,813 73.46 Loss of -339 on sale
2025-01-28BUY1,10273.15073.990 73.906USD 81,444 73.46
2025-01-27SELL-55172.64073.430 73.351USD -40,416 73.49 Profit of 74 on sale
2024-12-10SELL-55872.48073.100 73.038USD -40,755 73.60 Profit of 316 on sale
2024-12-03SELL-1,11872.03072.960 72.867USD -81,465 73.55 Profit of 762 on sale
2024-11-29SELL-55774.59076.080 75.931USD -42,294 73.52 Loss of -1,343 on sale
2024-11-25SELL-23,73273.52073.870 73.835USD -1,752,252 73.29 Loss of -13,010 on sale
2024-11-22SELL-1,94171.72072.000 71.972USD -139,698 73.36 Profit of 2,697 on sale
2024-11-05SELL-5,16877.28077.370 77.361USD -399,802 69.60 Loss of -40,128 on sale
2024-10-29BUY64573.60074.070 74.023USD 47,745 65.34
2024-10-24BUY64565.24065.910 65.843USD 42,469 65.34
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.